Bridion 200 MG/2 ML vial 2ML
Ended Awarded
- Contract number
- SPE2DB25FJ4VM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,200
Award facts
- Contract value 100% obligated
- $17,199.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,199.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Bridion (sugammadex) 200 mg/2 mL vials. The contract, which is not set-aside, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to furnish a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Bridion is a neuromuscular reversal agent used in military and civilian medical settings to reverse the effects of neuromuscular blocking agents during anesthesia. AmerisourceBergen's position as a major pharmaceutical distributor and critical federal medical procurement vendor is well-established through its extensive portfolio of federal contract awards with the Defense Logistics Agency and its Medical Supply Chain. The company's competitively awarded contracts consistently involve firm fixed-price delivery orders for diverse pharmaceutical products ranging from specialty medications to vaccines and medical devices, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJ4VM?
SPE2DB25FJ4VM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FJ4VM worth?
The government has obligated $17,200 on SPE2DB25FJ4VM.
Is contract SPE2DB25FJ4VM an order under another contract?
Yes. SPE2DB25FJ4VM is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4VM competed?
The extent of competition for SPE2DB25FJ4VM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award